Eli Lilly to add $4.1B U.S. sales from obesity drug Zepbound Markets November 12, 2023 hapabapa/iStock Editorial by way of Getty Photographs Gross sales from Eli Lilly’s (NYSE:LLY) newly permitted weight reduction treatment, Zepbound, may…
